IBDEI1UE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30850,1,3,0)
 ;;=3^Abnormal Liver Function Studies
 ;;^UTILITY(U,$J,358.3,30850,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,30850,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,30851,0)
 ;;=R94.6^^135^1384^21
 ;;^UTILITY(U,$J,358.3,30851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30851,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,30851,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,30851,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,30852,0)
 ;;=R94.7^^135^1384^5
 ;;^UTILITY(U,$J,358.3,30852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30852,1,3,0)
 ;;=3^Abnormal Endocrine Function Sutdies NEC
 ;;^UTILITY(U,$J,358.3,30852,1,4,0)
 ;;=4^R94.7
 ;;^UTILITY(U,$J,358.3,30852,2)
 ;;=^5019744
 ;;^UTILITY(U,$J,358.3,30853,0)
 ;;=R94.31^^135^1384^4
 ;;^UTILITY(U,$J,358.3,30853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30853,1,3,0)
 ;;=3^Abnormal EKG
 ;;^UTILITY(U,$J,358.3,30853,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,30853,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,30854,0)
 ;;=R97.0^^135^1384^67
 ;;^UTILITY(U,$J,358.3,30854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30854,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen 
 ;;^UTILITY(U,$J,358.3,30854,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,30854,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,30855,0)
 ;;=R97.1^^135^1384^66
 ;;^UTILITY(U,$J,358.3,30855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30855,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,30855,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,30855,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,30856,0)
 ;;=R97.2^^135^1384^68
 ;;^UTILITY(U,$J,358.3,30856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30856,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,30856,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,30856,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,30857,0)
 ;;=R97.8^^135^1384^22
 ;;^UTILITY(U,$J,358.3,30857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30857,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,30857,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,30857,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,30858,0)
 ;;=R93.8^^135^1384^12
 ;;^UTILITY(U,$J,358.3,30858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30858,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,30858,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,30858,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,30859,0)
 ;;=R93.1^^135^1384^14
 ;;^UTILITY(U,$J,358.3,30859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30859,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,30859,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,30859,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,30860,0)
 ;;=R68.83^^135^1384^48
 ;;^UTILITY(U,$J,358.3,30860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30860,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,30860,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,30860,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,30861,0)
 ;;=R68.2^^135^1384^62
 ;;^UTILITY(U,$J,358.3,30861,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30861,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,30861,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,30861,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,30862,0)
 ;;=R09.02^^135^1384^88
 ;;^UTILITY(U,$J,358.3,30862,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30862,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,30862,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,30862,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,30863,0)
 ;;=R39.81^^135^1384^92
 ;;^UTILITY(U,$J,358.3,30863,1,0)
 ;;=^358.31IA^4^2
